Ensocell
PrivateLast Round
Seed
May 7, 2024
Total Funding Raised
$16.3M
Company Overview
Ensocell is a biotechnology company that utilizes single-cell genomics and AI-based computational tools to discover precision biologics for autoimmune, inflammatory, and fibrotic diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ensocell Comparables
Compare Ensocell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Scailyte AG | 80% | |
| CytoReason | 77% | |
| Immunai | 77% | |
Ensocell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 7, 2024 |
Ensocell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OMX Ventures | Seed |
| Sofinnova Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2026
Monthly visitors grew 103% MoM, reaching 1.8K.
- Jun 7, 2025
Grew 20% QoQ, from 15 to 18 employees.
Ensocell Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ensocell's valuation, stock price, and market status.